Drugs Information:
Bremelanotide
Basic Information
|
||
| ID | DDInter227 | |
| Drug Type | biotech | |
| Protein Chemical Formula | None | |
| Protein Average Weight | - | |
| CAS Number | 189691-06-3 | |
| Description | Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.[L9635] Bremelanotide does not interact with alcohol.[A179686] The mechanism by which bremelanotide's action on receptors translates to a clinical effect is still unknown.[L9635] Bremelanotide was first described in the literature in 2003 when it was known by the investigational code PT-141.[A179683] Since then it was investigated for its place in treating sexual dysfunction in men and women but is now only indicated for women.[A179683,A179686,L9635] Other drugs used to treat female sexual dysfunction include [flibanserin], [estrogen], [ospemifene], and [prasterone].[A179689] Bremelanotide was granted FDA approval on 21 June 2019.[L9635] | |
| ATC Classification | G02CX05 | |
| Sequences | None | |
| Useful Links | DrugBank ChEBI PubChem Substance ChemSpider BindingDB Wikipedia ChEMBL | |
Interactions with
Bremelanotide
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|